ACST insider filings

Acasti Pharma Inc. — 37 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-05-10. Screen ACST transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ACST between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Acasti Pharma Inc.

FiledFormInsiderReported transactionsSource
2024-05-104/AD'Andrea Carrie — VP Clinical OperationsGrant/award (A): 19,740 (derivative) @ $0EDGAR
2024-05-104/AKumar Amresh — VP Program ManagementGrant/award (A): 19,740 (derivative) @ $0EDGAR
2024-05-084D'Andrea Carrie — VP Program ManagementGrant/award (A): 19,740 (derivative) @ $0EDGAR
2024-05-084Kumar Amresh — VP Clinical OperationsGrant/award (A): 19,740 (derivative) @ $0EDGAR
2024-05-084Macdonald R. Loch — Chief Medical OfficerGrant/award (A): 25,380 (derivative) @ $0EDGAR
2024-05-084DelAversano Robert J — Principal Financial OfficerGrant/award (A): 4,500 (derivative) @ $0EDGAR
2024-05-084Kohli Prashant — Chief Executive Officer, DirectorGrant/award (A): 128,770 (derivative) @ $0EDGAR
2023-12-204Kavuru Vimal — Director, 10% ownerGrant/award (A): 10,000 (derivative) @ $0EDGAR
2023-12-204Kottayil George — DirectorGrant/award (A): 22,500 (derivative) @ $0EDGAR
2023-12-204Kohli Prashant — Chief Executive Officer, DirectorGrant/award (A): 41,668 (derivative) @ $0EDGAR
2023-12-204NEUGEBOREN EDWARD — DirectorGrant/award (A): 22,500 (derivative) @ $0EDGAR
2023-12-204DAVIS A BRIAN — DirectorGrant/award (A): 22,500 (derivative) @ $0EDGAR
2023-09-274Kavuru Vimal — Director, 10% ownerPurchase (P): 676,371 @ $1.85 · Purchase (P): 422,732 (derivative) @ $0.12EDGAR
2023-09-054Olds Donald — DirectorPurchase (P): 381 @ $2.05EDGAR
2023-07-184Derby Michael — DirectorGrant/award (A): 12,500 (derivative) @ $0EDGAR
2023-07-184Kavuru Vimal — DirectorGrant/award (A): 12,500 (derivative) @ $0EDGAR
2023-07-184Olds Donald — DirectorGrant/award (A): 12,500 (derivative) @ $0EDGAR
2023-07-184Macdonald R. Loch — Chief Medical OfficerGrant/award (A): 60,000 (derivative) @ $0EDGAR
2023-07-184D'Andrea Carrie — VP Clinical OperationsGrant/award (A): 42,000 (derivative) @ $0EDGAR
2023-07-184Kumar Amresh — VP Program ManagementGrant/award (A): 42,000 (derivative) @ $0EDGAR
2023-07-184Kohli Prashant — Chief Executive OfficerGrant/award (A): 208,334 (derivative) @ $0EDGAR
2022-09-304Kavuru Vimal — DirectorGrant/award (A): 45,000 (derivative) @ $0EDGAR
2022-09-304Olds Donald — DirectorGrant/award (A): 45,000 (derivative) @ $0EDGAR
2022-09-304Derby Michael — DirectorGrant/award (A): 85,000 (derivative) @ $0EDGAR
2022-09-304Canan John — DirectorGrant/award (A): 45,000 (derivative) @ $0EDGAR
2022-06-234Lemieux Pierre — COO, Canada & CSOGrant/award (A): 165,000 (derivative) @ $0EDGAR
2022-06-234Kottayil George — COO, USGrant/award (A): 50,000 (derivative) @ $0EDGAR
2022-06-234Ford Brian D. — CHIEF FINANCIAL OFFICERGrant/award (A): 165,000 (derivative) @ $0EDGAR
2022-06-234D'Alvise Janelle — PRESIDENT & CEO, DirectorGrant/award (A): 560,000 (derivative) @ $0EDGAR
2021-11-164Olds Donald — DirectorGrant/award (A): 42,100 (derivative) @ $0EDGAR
2021-11-164Lemieux Pierre — COO, Canada & CSOGrant/award (A): 287,900 (derivative) @ $0EDGAR
2021-11-164Kavuru Vimal — DirectorGrant/award (A): 42,100 (derivative) @ $0EDGAR
2021-11-164HASELTINE WILLIAM A — DirectorGrant/award (A): 42,100 (derivative) @ $0EDGAR
2021-11-164Ford Brian D. — CHIEF FINANCIAL OFFICERGrant/award (A): 287,900 (derivative) @ $0EDGAR
2021-11-164D'Alvise Janelle — PRESIDENT & CEO, DirectorGrant/award (A): 655,500 (derivative) @ $0EDGAR
2021-11-164Carter Roderick Noel — DirectorGrant/award (A): 42,100 (derivative) @ $0EDGAR
2021-11-164Canan John — DirectorGrant/award (A): 42,100 (derivative) @ $0EDGAR

Recent 8-K events — Acasti Pharma Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-188-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-08-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-068-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-288-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-188-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-188-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-058-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-278-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-238-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ACST returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs